The roles of serum mannan binding protein (MBP) and the mannose receptor in the cellular uptake of mannosylated liposomes (Man-liposomes) by macrophages were studied. Man-liposomes were prepared by incorporating cholesten-5yloxy-N-(4-((1-imino-2-L-D-thiomannosylethyl)amino)butyl)formamide (Man-C4-Chol) into small unilamellar long circulating liposomes consisting of cholesterol (Chol) and distearoyl phosphatidylcholine (DSPC). In the in vitro cellular uptake study with cultured mouse peritoneal macrophages, [ 3 H]Man-liposomes were taken up to a great extent, whereas no significant uptake was observed for [ 3 H]cholesterol and DSPC liposomes without Man-C4-Chol (Bare-liposomes). The uptake of [ 3 H]Man-liposomes was dose-and temperature-dependent and inhibited by an excess of mannosylated bovine serum albumin, suggesting their specific uptake via membrane mannose receptor-mediated endocytosis. Furthermore, it was demonstrated that 111 In-MBP binds strongly to Man-liposomes based on the recognition of Man-C4-Chol and markedly enhanced their uptake by macrophages. These results are supported by confocal laser microscopic images. In addition, in vivo hepatic uptake of 111 In-MBP was enhanced by Man-liposomes. On the other hand, the uptake of Man-liposomes was significantly reduced by preincubation with serum and further with MBP-depleted serum suggesting inhibitory effects of serum proteins such as albumin on mannose receptor-mediated endocytosis. The involvement of serum-type MBP and membrane mannose receptors in the uptake of Man-liposomes is thus suggested. ß
Introduction
The use of liposomes coated with ligands for receptors on cells is a promising approach for cell-spe-ci¢c drug delivery. Among the di¡erent receptors present on the surface of macrophages, the lectin speci¢c for mannose residues is a promising candidate for liposomal targeting. Several investigators, including us, have reported using mannose-modi¢ed liposomes to deliver drugs, gene, antigens, and immunomodulators to macrophages [1^3] and demonstrated their uptake by macrophages via mannose receptor-mediated endocytosis. The mannose receptor is a 175 kDa type I transmembrane protein and one of the C-type lectin family containing multiple carbohydrate recognition domains. It is expressed on Kup¡er cells [4] , alveolar [5] , peritoneal [6] , and splenic macrophages [7] , monocyte-derived dendritic cells [8] , and subsets of vascular and lymphatic endothelial cells [9] . Several in vivo functions have been proposed for the mannose receptor on macrophages, e.g. endocytosis of extracellular peroxidases and hydrolysis during the resolution phase of in£ammation, phagocytosis of unopsonized pathogens [10] , and antigen capture for eventual presentation to T cells [11] .
Besides mannose receptors, mannan binding proteins (MBPs) also bind to a variety of pathogens by recognizing D-mannose, N-acetyl-D-glucosamine, or L-fucose on their surface [12] . Serum-type MBP is characterized as an oligomeric serum protein of hepatic origin and belongs to the family of Ca 2 -dependent collagenous lectins, most of which are components of the innate immune systems of mammals [13] . It can also activate the complement system following binding to its ligands in an antibody-or C1qindependent manner (opsonin-dependent) [14] .
In a series of our investigations, we have established a novel method of introducing sugar moieties directly into cholesterol derivatives and synthesized cholesten-5-yloxy-N-(4-((1-imino-2-L-D-thiomannosylethyl)amino)alkyl)formamide (Man-C4-Chol) [15] . The novel mannosylated liposomes, consisting of Man-C4-Chol, neutral distearoyl phosphatidylcholine (DSPC), and cholesterol(Chol) (Man-liposomes), were rapidly eliminated from the blood circulation and accumulate to a great extent in the liver after intravenous administration to mice compared with DSPC/Chol liposomes [16] . It has also been suggested that uptake is mainly due to the liver nonparenchymal cells and is signi¢cantly inhibited by preadministration of mannosylated bovine serum albumin (Man-BSA). In the present study, we describe the hepatic uptake characteristics of Man-liposomes in more detail. In particular, our discussion will focus on the involvement of serum MBP and the macrophage membrane mannose receptor.
Materials and methods

Materials
DSPC and cholesteryl chloroformate were pur-chased from Sigma Chemical (St. Louis, MO, USA). Chol was obtained from Nacalai Tesque (Kyoto, Japan). [ 3 H]Cholesteryl hexadecyl ether (CHE) was purchased from NEN Life Science Products (Boston, MA, USA). Indium chloride ( 111 In) was supplied by Nihon MedioPhysics (Takarazuka, Japan). Man-BSA with an average degree of conjugation of 46 molecules per albumin molecule was synthesized as reported previously [17] . All other chemicals were reagent grade products obtained commercially. Male ICR mice and ddY mice were obtained from the Shizuoka Agriculture Cooperative Association for Laboratory Animals (Shizuoka, Japan).
Synthesis of Man-C4-Chol
Man-C4-Chol was synthesized by the method described previously [16] . Brie£y, cholesteryl chloroformate was reacted with N-(4-aminobutyl)carbamic acid tert-butyl ester in chloroform at room temperature for 24 h and then incubated with tri£uoroacetic acid at 4³C for 4 h. N-(4-Aminobutyl)-(cholesten-5yloxy)formamide was obtained after evaporation of the solvent. A quantity of the resultant material was added to an excess amount of 2-imino-2-methoxyethyl-1-thiomannoside [17] in pyridine containing triethylamine. After 24 h at room temperature, the reaction mixture was evaporated, resuspended in water and dialyzed to remove any unreacted compound and, ¢nally, lyophilized.
Preparation of liposomes
DSPC/Chol (60:40, molar ratio) and DSPC/Chol/ Man-C4-Chol (60:35:5, molar ratio) liposomes were prepared by the method described previously [18] . Brie£y, lipids with a trace amount of [ 3 H]CHE were dissolved in chloroform and evaporated to dryness in a round-bottomed £ask. For confocal microscopy, £uorescent PE-rhodamine (1 mol%) was added to the chloroform. The dried lipid ¢lm was then vacuum-desiccated for at least 4 h to remove any residual organic solvent before it was hydrated in phosphate-bu¡ered saline (PBS, pH 7.4). The suspension was sonicated at 65³C for 3 min, then extruded ¢ve times at 65³C through 200 nm and 100 nm pore size polycarbonate membranes. The mean vesicle diame-ters were determined using a laser light scattering particle size analyzer (LS-900, Otsuka Electronics, Osaka, Japan). The lipid compositions and mean particle sizes are shown in Table 1 .
Preparation of serum and MBP-depleted serum
Blood was obtained from the vena cava of ICR mice under ether anesthesia and left at room temperature for 1 h, then kept overnight at 4³C. Serum was obtained by centrifugation at 10 000Ug for 10 min at 4³C then frozen at 320³C until required. MBP-depleted serum was obtained by applying the serum twice, at a rate of 1 drop/15 s, to an a¤nity column of mannan Sepharose 4B that had been equilibrated with loading bu¡er containing 1.25 M NaCl, 20 mM CaCl 2 , and 20 mM imidazole. Then the column was washed with elution bu¡er containing 20 mM imidazole^HCl, pH 7.8, 1.25 M NaCl, and 2 mM EDTA. Liposomes were incubated with serum at 37³C for 10 min before starting the uptake experiment.
Harvesting and culture of macrophages
Resident macrophages were collected from the peritoneal cavity of male ICR mice weighing 20^25 g using balanced salt solution A. Washed cells were suspended in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum (FBS, Flow Laboratories, Irvine, UK), penicillin G (100 U/ml), and streptomycin (100 Wg/ml) and then plated on 12-well culture plates (Falcon, Becton Dickinson, Lincoln Park, NJ, USA) at a density of 1U10 6 cells/cm 2 . After incubation for 2 h at 37³C in 5% CO 2^9 5% air, adherent macrophages were washed with culture medium and then cultured under the same conditions.
Cellular uptake study
Uptake studies were carried out after 48 h cultivation. Cells were washed twice with 1 ml pH 7.4 Hanks' balanced salt solution (HBSS). The liposomes were preincubated at 37³C for 10 min with bu¡er, MBP, serum, or MBP-depleted serum before cellular uptake studies. The opsonized liposomes were added to the cells and incubated at 37³C for the uptake experiments or incubated at 4³C for the binding experiments. At the end of the incubation period, the medium was removed and the cells were washed ¢ve times with cold HBSS. The cells were solubilized with 0.5 ml 1 N NaOH solution overnight and then neutralized with 0.1 ml 5 N HCl solution. The radioactivity of [ 3 H]CHE was measured in a scintillation counter (LSA-500, Beckman, Tokyo, Japan) after addition of 5.0 ml Clear-Sol I solution. The protein content was also measured by the Bradford method using BSA as a standard [19] .
Isolation of mannose binding proteins from rabbit serum and 111 In or FITC labeling
Serum MBP was isolated from normal rabbit serum (Japan Bio-supply) using an a¤nity column of Sepharose 4B^mannan, as described previously [20] . Brie£y, frozen rabbit serum was thawed and diluted with an equal volume of a bu¡er consisting of 40 mM imidazole^HCl, pH 7.8, 40 mM CaCl 2 W2H 2 O, and 2.5 M NaCl. The mixture was applied to the Sepharose 4B^mannan column equilibrated with loading bu¡er (20 mM imidazole^HCl, pH 7.8, 20 mM CaCl 2 W2H 2 O, and 1.25 M NaCl) and the bound protein was eluted with an elution bu¡er (20 mM imidazole^HCl, pH 7.8, 1.25 M NaCl, and 2 mM EDTA). The eluate was applied to the second and third smaller a¤nity columns of Sepharose 4B^man- Table 1 Lipid composition and mean particle size of the tested liposomes nan. The ¢nal column was washed with loading bu¡er and eluted with more loading bu¡er containing 100 mM mannose. All the procedures were carried out at 4³C. The isolated protein was subjected to SDS^PAGE (10% w/v acrylamide) under reducing and non-reducing conditions by the method of Laemmli [21] . Molecular weights were estimated by comparison with Rainbow marker proteins (Amersham Life Sciences).
MBP was radiolabeled with 111 In using the bifunctional chelating agent diethylenetriaminepentaacetic acid (DTPA) anhydride (Dojindo Labs, Kumamoto, Japan) by the method of Hnatowich et al. [22] . Brie£y, 10 Wl DTPA anhydride in dimethyl sulfoxide was added to MBP solution. The mixture was stirred for 30 min at room temperature, puri¢ed by gel ¢ltration chromatography using a PD-10 column (Pharmacia, Uppsala, Sweden), and eluted with 50 mM HEPES bu¡er (pH 7.8) containing 600 mM NaCl to remove the unreacted DTPA. The fractions containing protein derivatives were collected and 111 InCl 3 solution was added to the DTPA-coupled MBP. After 30 min, the mixture was puri¢ed by passing it through a PD-10 column and eluting with 50 mM HEPES bu¡er (pH 7.8) containing 600 mM NaCl. The fractions containing 111 In-MBP were collected and the protein concentration was determined by the Bradford method using BSA as a standard [19] .
For the confocal microscopic study, MBP was labeled with £uorescein isothiocyanate (FITC) as described previously [23] . 200 Wg MBP was incubated with 500 Wg FITC in 50 mM borate bu¡er (pH 9.5) containing 200 mM NaCl, 20 mM CaCl 2 , and 100 mM mannose for 18 h at 4³C. The fractions containing FITC-MBP were collected from a PD-10 column and puri¢ed by dialysis with water at 4³C overnight.
Binding of 111 In-MBP to liposomes
The binding of 111 In-MBP to liposomes was tested by the sedimentation method [24] . The liposomes (500 Wg) and the 111 In-MBP (1 Wg) in 20 mM Tris bu¡er (pH 7.4) containing 0.15 M NaCl, 5 mM CaCl 2 , and 20 mg/ml BSA were separately centrifuged at 10 000Ug for 10 min. In the inhibition experiment, 10 mM EDTA or 100 mM mannose was added in Tris bu¡er. Each liposome pellet was then suspended in 250 Wl of the supernatant from the 111 In-MBP solution. The liposome^protein mixture was incubated for 1 h at room temperature, placed on ice, and incubated for 15 min. The mixture was centrifuged at 10 000Ug for 10 min at 4³C. The supernatant was stored and the precipitate was washed once with 250 Wl ice-cold Tris bu¡er. After centrifuging, the supernatants were combined. The amount of 111 In-MBP bound to the liposomes was estimated by counting the radioactivity in a well-type NaI scintillation counter (ARC-500, Aloka Co., Tokyo, Japan).
Confocal microscopy
For the confocal microscopy study, resident macrophages were cultured at a density of 1U10 5 cells/ well on a glass-bottom 12-well plate and incubated at 4³C or 37³C with PE-rhodamine liposomes, with or without preincubation with FITC-MBP. After appropriate time intervals, the cells were washed ¢ve times with ice-cold HBSS and then ¢xed with 4% paraformaldehyde and 0.01% glutaraldehyde in PBS(+), and stored overnight at 4³C. The cells were mounted in 2.5% DABCO, 90% glycerol, and PBS(+). The samples were examined by confocal laser microscope (ACAS 570 interactive laser cytometer, Meridian Instruments, Okemos, MI, USA).
In vivo distribution of 111 In-MBP
111 In-MBP (2 Wg), with or without preincubation with Bare-liposomes or Man-liposomes (500 Wg), was injected intravenously into a male ddY mouse (25^28 g) via the lateral tail vein. At predetermined time periods (1, 3, 5, 10, 30, and 60 min) after injection, blood was collected from the vena cava under ether anesthesia. The mouse was then sacri¢ced and its liver, spleen, kidney, and muscle were removed, rinsed with saline, weighed and their radioactivity assayed in a well-type NaI scintillation counter (ARC-500, Aloka Co., Japan).
Calculation of pharmacokinetic parameters
The distribution data of 111 In-MBP were analyzed in terms of the organ uptake clearance (CL org ) [25] .
After injection of 111 In-labeled compound, the change in the amount of radioactivity in a tissue with time can be described as
where X i (normalized to % of the dose) represents the amount of radioactivity in tissue i after the administration of the 111 In-labeled compound; C p (% of dose/ml) is the concentration of radioactivity in the plasma; CL org (ml/h) represents the apparent tissue uptake clearance from the plasma to tissue i; and K effluxYi (h 31 ) represents an e¥ux rate constant from tissue i. Since little e¥ux of 111 In radioactivity from tissues was observed within the overall experimental period of 1 h, the e¥ux process can be ignored and Eq. 1 is simpli¢ed to
When Eq. 2 is integrated from time 0 to t, CL org can be expressed as
where AUC t (% of dose h/ml) represents the area under the plasma concentration^time curve from time 0 to t, calculated by ¢tting a monoexponential equation to the plasma concentration^time data of the 111 In radioactivity^time pro¢le using the non-linear least-squares program MULTI [26] . Therefore, CL org can be easily calculated from Eq. 3 at several time points after administration. The total body clearance (CL total ) can be calculated by dividing the dose by the AUC up to in¢nity. Fig. 1A shows the dose-dependent in vitro uptake of 3 H-labeled liposomes by cultured mouse resident peritoneal macrophages at 37³C. Uptake of Manliposomes at 2 h was approximately eight-fold great-er than that of Bare-liposomes. The cellular uptake increased with time at both 37³C and 4³C (Fig. 1B) but the cellular uptake of Bare-liposomes was markedly lower than that of Man-liposomes at 37³C.
Results
Uptake by cultured macrophages
Uptake inhibition experiment
Uptake experiments were carried out, with or without an excess amount of Man-BSA. Fig. 2 shows a signi¢cant inhibitory e¡ect of Man-BSA on Manliposome uptake (P 6 0.001) by macrophages, whereas no signi¢cant uptake was observed for Bare-liposomes.
Uptake of [ 3 H]liposomes preincubated with serum-type MBP
Under reducing conditions, a single band (about 30 kDa) could be detected on the SDS^PAGE of the protein(s) puri¢ed from rabbit serum or mouse serum using an a¤nity column (Fig. 3) . On the other hand, several high molecular weight bands were seen under non-reducing conditions. These results agreed with those of previous papers [20, 27] , indicating that both proteins puri¢ed from rabbit and mouse serum The results are expressed as the mean þ S.D. of three experiments. are serum-type MBP. To clarify the e¡ect of MBP, [ 3 H]liposomes were preincubated with MBP at 37³C for 10 min before the uptake experiment. It is obvious from Fig. 4 
Binding of 111 In-MBP to liposomes
The binding of 111 In-MBP to liposomes was deter-mined by the sedimentation method and the results are summarized in Table 2 . This shows that an approximately two-fold greater amount of 111 In-MBP was co-sedimented with Man-liposomes than Bareliposomes and this binding was also inhibited by 10 mM EDTA or 100 mM mannose.
E¡ect of serum on the uptake
The e¡ects of serum or its components on in vitro uptake were investigated. The results in Fig. 5 show that the uptake of Man-liposomes incubated with serum signi¢cantly decreased on increasing the concentration of serum. The uptake of liposomes by macrophages in the presence of serum, with or without MBP, is compared in Fig. 6 . The uptake of Bareliposomes by macrophages was una¡ected by both serum samples. On the other hand, serum drastically suppressed the uptake of Man-liposomes by macrophages, but the uptake was still greater than that for Bare-liposomes. Man-liposomes preincubated with MBP-depleted serum showed a signi¢cantly lower uptake than with normal serum indicating involvement of MBP in the uptake of Man-liposomes by macrophages. 
Confocal microscopy
The results of confocal microscopy are shown in Fig. 7 and these suggest close agreement with those obtained in the in vitro uptake experiment. Confocal microscopy images revealed time-dependent binding at 4³C (Fig. 7A ) and internalization at 37³C (Fig.  7B) of Man-liposomes by macrophages. In addition, about 50% of the bound Man-liposomes were internalized in 30 min (data not shown). Bare-liposomes showed a similar pattern of binding and internalization, but the number of cells exhibiting binding and internalization was less than 10% of the total cells, whereas the ¢gure was more than 90% for Man-liposomes.
To clarify the e¡ect of MBP on the uptake of Man-liposomes, colocalization images were examined (Fig. 8) . The photographs show that FITC-MBP ( Fig. 8A ) was internalized into macrophages, but the £uorescence signal was rather weaker than that of the complex with PE-rhodamine Bare-liposomes ( Fig. 8B) and PE-rhodamine Man-liposomes (Fig.  8E ). FITC-MBP preincubated with PE-rhodamine Bare-liposomes ( Fig. 8D ) and with PE-rhodamine Man-liposomes (Fig. 8G) is internalized into macrophages. As shown by the yellow signal depicting colocalization, FITC-MBP exhibited increased colocalization with PE-rhodamine Man-liposomes and PErhodamine Bare-liposomes. The number of cells exhibiting colocalization of PE-rhodamine Bare-liposomes with FITC-MBP was less than 10% of the total cells, whereas more than 90% of cells showed colocalization for Man-liposomes. Fig. 9 shows the plasma concentration and liver accumulation time courses of 111 In-MBP after intravenous injection in mice, with or without preincuba-tion with Bare-liposomes and Man-liposomes. Although 111 In-MBP was mainly recovered in the liver in all cases, the hepatic uptake of 111 In-MBP preincubated with Man-liposomes was the greatest. Table 3 summarizes the AUC, CL total , hepatic uptake clearance (CL liver ), and tissue uptake rate index of 111 In-MBP after intravenous injection. The CL liver made a major contribution to the CL total , suggesting that the liver is the main organ for 111 In-MBP uptake. The results con¢rmed that binding to Man-liposomes enhanced the hepatic uptake of 111 In-MBP.
In vivo distribution of 111 In-MBP
Discussion
Cell-speci¢c targeting systems using carbohydrate recognition mechanisms have attracted great interest as far as drug and gene delivery are concerned, and we have reported developments of various polymeric or particulate carriers in this context [28^30]. However, in order to achieve highly speci¢c cellular targeting via receptor-mediated endocytosis, we need to pay great attention to interactions of carriers with biological components such as serum binding protein. For example, Kawasaki et al. [31] reported that MBP, mannose-speci¢c lectin, circulates in serum, binds to pathogens having mannose units on their surface, and functions directly as an opsonin recognized by the collectin receptor on macrophages [32, 33] and complement activation [34, 35] . In our series of investigations, we have described the e¡ect of speci¢c binding to MBP on the targeting potential of mannosylated polymer carriers in mice. Dose-dependent reiteration of cell-speci¢c hepatic uptake due to complex formation was con¢rmed by a pharmacokinetic analysis (submitted): serum MBP retarded hepatic uptake of mannosylated polymer at lower doses of 0.05 and 0.1 mg/kg. At doses between 0.1 and 1 mg/kg, the binding to MBP was saturated and excess ligands existing in a free form were recognized by hepatic mannose receptors resulting in rapid hepatic uptake. At doses over 1 mg/kg, the mannose receptors were also saturated with ligands and the hepatic uptake was retarded again. A similar phenomenon would be suspected for particulate carriers such as mannosylated liposomes, but little information has been obtained about the e¡ects of MBP on the in vivo behavior of Man-liposomes. Therefore, in this investigation, the roles of MBP and mannose receptor in the uptake of Man-liposomes by macrophages were studied in detail. In general, liposome composed of DSPC and Chol and small in size, such as 6 100 nm, are known to have a long half-life in the blood circulation due to their ability to avoid reticuloendothelial systems (RES) trapping [36] , failure to undergo complement activation [37] , and a lower susceptibility to destruction by serum components [38] . Therefore, in our approach, we chose DSPC/Chol liposomes as Bareliposomes for modi¢cation with Man-C4-Chol to obtain mannosylated targeting liposomes. The in vitro uptake experiment demonstrated the rapid attachment and internalization of Man-liposomes by peritoneal macrophages (Fig. 1) and similar results were obtained by confocal microscopy observations (Fig.  7) . Furthermore, the uptake was dose-dependent ( Fig. 1) and inhibited by Man-BSA (Fig. 2) . These results suggest that the mannose residues on the surface of Man-liposomes present a conformational mobility which allows interaction with the mannose receptors of the macrophages under serum-free conditions. However, this may not be the case in vivo since administered liposomes would be exposed to serum components including MBP.
When mannosylated ligands interact with serum, their biodistribution becomes more complicated. The serum components that can recognize the mannose moiety or simply be adsorbed on Man-liposomes may accelerate (opsonins) or suppress (disopsonins) the mannose-speci¢c uptake of Manliposomes, respectively. Thus, the apparent hepatic disposition feather would be observed in the balance of the acceleration and suppression. In Fig. 4 puri¢ed MBP enhanced the uptake of both Bare-liposomes and Man-liposomes but the increase was greater for Man-liposomes. These results are in good agreement with the results of confocal microscopy in that the number of cells exhibiting colocalization of FITC-MBP and PE-rhodamine-labeled liposomes for Bare-liposomes was less than 10% of total cells, whereas it was more than 90% for Man-liposomes. The enhancement of the uptake of Bare-liposomes by MBP might be provoked by the non-speci¢c adsorption on the liposomal surface or the speci¢c binding of MBP to phospholipids since binding of MBP to phospholipids and liposomes in addition to mannose moieties was also reported in previous studies [39] . In vivo experiments also demonstrated that only Manliposomes enhanced the hepatic uptake of 111 In-MBP ( Fig. 9 ) suggesting e¡ective uptake of the complex of MBP and Man-liposomes by macrophages. Moreover, [ 3 H]CHE-labeled Man-liposomes complexed with 111 In-MBP showed greater uptake than [ 3 H]liposomes administered alone (data not show). Serum albumin, the major serum protein, has been reported to reduce the hepatic uptake of polystyrene colloidal particles by coating the hydrophobic surface of particles [40] . In this study, the uptake experiments demonstrated that serum components present on the surface of Man-liposomes suppressed its cellular uptake (Fig. 5) , probably due to disruption of the speci¢c interaction between the mannose moiety and the receptor on the macrophages. A similar effect was observed for serum heated at 56³C for 30 min (decomplemented serum) (data not shown). These results suggest that heat-stable serum components such as albumin might coat the liposomal surface and inhibit recognition. This result seems to be inconsistent with the previous report of Matsuo et al. [41] who demonstrated stimulatory and inhibitory e¡ects of serum and heated serum, respectively, on the uptake of multilamellar vesicles with cetylmannoside in the in situ hepatic uptake experiments. They suggested the involvement of complement but not the mannose receptor. This discrepancy could be due to di¡erences in the size and types of the mannose moieties as well as lipid composition of the liposomes. On the other hand, MBP-depleted serum showed a signi¢cantly higher uptake inhibition for Man-liposomes than normal serum, suggesting involvement of MBP in uptake by macrophages ( Fig. 6 ). Further study is necessary to clarify the detailed role of serum components in the suppression of cellular uptake of liposomes.
In a previous study, we have found that the soluble mannosylated polymer complexed with MBP loses its ability to be recognized by macrophages (submitted). Although the structure, functions, and manner of binding to simple sugar of MBP have been extensively studied [13^15], no study has so far shown the relationship between the characteristics of the mannosylated ligands and the uptake e¤ciency of its MBP complex. The critical features of the ligands, such as their size and shape and the mechanisms of inhibition or stimulation of MBP on the uptake of mannosylated ligands, remain to be elucidated. It has been reported that MBP can be recognized by collectin receptors expressed on macrophages, monocytes, and neutrophils [42] and the collagen-like N-terminal region of MBP is responsible for this interaction. It has been hypothesized that the collagenous region of the MBP motif is normally masked by the MBP-associated serine protease (MASP). However, following complement activation, MASP is removed to reveal the collectin receptor binding sites. Alternatively, binding of mannosylated ligands to the carbohydrate recognition domain region might result in a conformational change in the collagenous region with exposure of a previously hidden site, leading to binding and inter-nalization of the MBP/mannosylated ligand complex into the macrophages by collectin receptors [43] . In the case of soluble mannosylated polymers, MBP hides mannose moieties while retaining its soluble form. Although the interaction between MBP and mannosylated polymeric ligands leads to tight and speci¢c binding through multivalent interaction, it could not produce a conformational change in the collagenous region in MBP. These di¡erences could be explained in terms of the size and shape of the ligands, rather than the clustering e¡ect of the multivalent interaction. Thus, the characteristics of mannosylated ligands are crucial as far as exposure of the binding sites of the collagenous region is concerned.
Native and recombinant MBP have been shown to bind to virulent S. montevideo expressing a mannoserich O-polysaccharide which results in attachment, uptake, and killing of the coated bacteria by phagocytes, providing the ¢rst evidence that MBP can act as an opsonin [44] . Thus, it has been presumed that this direct opsonin activity is mediated by a collectin-speci¢c receptor expressed on phagocytic cell surfaces, although the physiological importance of the MBP interaction with the collectin receptor(s) remains unclear due to the absence of data on receptor kinetics and expression. On the other hand, Tenner et al. [45] recently showed that MBP does not associate or bind to the target being ingested. Rather, cellular interaction with MBP alone induces, as yet unknown, intracellular responses, possibly binding of a target to independent recognition receptors like FcR or CR1. The exact mechanism involved needs further investigation.
In summary, the novel mannosylated liposomes developed for liver non-parenchymal cell selective targeting were con¢rmed to be recognized by the mannose receptors of macrophages with a high degree of speci¢city. In addition to the mannose receptor, serum MBP speci¢cally associates at the surface of Man-liposomes and enhances its binding and internalization by macrophages. On the other hand, some components in serum simply interfere with the recognition by coating the surface of liposomes. The characterization of these interactions between Man-liposomes and the macrophage receptors or MBP would not only provide fundamental information for the rational design of cell-speci¢c carriers, but also suggest a role of these interactions in infec-tion and other pathological conditions involving macrophages.
